- Home
- EDRY vs IXHL Comparison
EDRY vs IXHL Comparison
Compare EDRY & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDRY
- IXHL
- Stock Information
- Founded
- EDRY 2018
- IXHL 2001
- Country
- EDRY Greece
- IXHL Australia
- Employees
- EDRY N/A
- IXHL 9
- Industry
- EDRY Marine Transportation
- IXHL
- Sector
- EDRY Consumer Discretionary
- IXHL
- Exchange
- EDRY Nasdaq
- IXHL Nasdaq
- Market Cap
- EDRY 25.2M
- IXHL 20.5M
- IPO Year
- EDRY N/A
- IXHL N/A
- Fundamental
- Price
- EDRY $10.24
- IXHL $0.21
- Analyst Decision
- EDRY
- IXHL
- Analyst Count
- EDRY 0
- IXHL 0
- Target Price
- EDRY N/A
- IXHL N/A
- AVG Volume (30 Days)
- EDRY 8.2K
- IXHL 38.5M
- Earning Date
- EDRY 06-05-2025
- IXHL 05-15-2025
- Dividend Yield
- EDRY N/A
- IXHL N/A
- EPS Growth
- EDRY N/A
- IXHL N/A
- EPS
- EDRY N/A
- IXHL N/A
- Revenue
- EDRY $55,867,583.00
- IXHL $98,000.00
- Revenue This Year
- EDRY N/A
- IXHL $3,817.06
- Revenue Next Year
- EDRY $28.27
- IXHL $66.67
- P/E Ratio
- EDRY N/A
- IXHL N/A
- Revenue Growth
- EDRY 10.25
- IXHL N/A
- 52 Week Low
- EDRY $7.60
- IXHL $0.08
- 52 Week High
- EDRY $24.80
- IXHL $3.37
- Technical
- Relative Strength Index (RSI)
- EDRY 52.46
- IXHL 46.27
- Support Level
- EDRY $8.95
- IXHL $0.20
- Resistance Level
- EDRY $9.34
- IXHL $0.23
- Average True Range (ATR)
- EDRY 0.53
- IXHL 0.02
- MACD
- EDRY 0.06
- IXHL 0.01
- Stochastic Oscillator
- EDRY 28.60
- IXHL 42.50
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.